Detalhe da pesquisa
1.
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.
BMC Cancer
; 23(1): 907, 2023 Sep 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37752419
2.
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.
Acta Oncol
; 57(7): 958-964, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29533113
3.
Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome.
Ann Oncol
; 27(9): 1788-93, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27287205
4.
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression.
Ann Oncol
; 25(10): 2080-2086, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25015333
5.
Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.
Pharmacogenomics J
; 12(6): 476-83, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21826087
6.
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity.
Oncogene
; 26(46): 6604-18, 2007 Oct 11.
Artigo
Inglês
| MEDLINE | ID: mdl-17471235
7.
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.
Ann Oncol
; 19(8): 1500-1508, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18385200
8.
Interphase cytogenetics for the detection of the t(11;22)(q24;q12) in small round cell tumors.
J Clin Invest
; 90(5): 1911-8, 1992 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-1430213
9.
Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma.
Cytogenet Genome Res
; 119(1-2): 21-6, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-18160777
10.
Anticancer effects of zoledronic acid against human osteosarcoma cells.
J Orthop Res
; 24(6): 1145-52, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16602111
11.
Prognostic and therapeutic targets in the Ewing's family of tumors (PROTHETS).
Adv Exp Med Biol
; 587: 1-12, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17163151
12.
CD99 engagement: an effective therapeutic strategy for Ewing tumors.
Cancer Res
; 60(18): 5134-42, 2000 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-11016640
13.
Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.
Cancer Res
; 49(13): 3631-6, 1989 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-2471586
14.
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.
Cancer Res
; 58(18): 4127-31, 1998 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-9751624
15.
Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target.
Cancer Res
; 56(20): 4570-4, 1996 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-8840962
16.
Multidrug resistance and malignancy in human osteosarcoma.
Cancer Res
; 56(10): 2434-9, 1996 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-8625324
17.
CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling.
Oncogene
; 35(30): 3944-54, 2016 07 28.
Artigo
Inglês
| MEDLINE | ID: mdl-26616853
18.
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.
Oncogene
; 18(3): 739-46, 1999 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-9989824
19.
The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Oncogene
; 10(4): 739-49, 1995 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-7862451
20.
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.
Oncogene
; 12(8): 1697-705, 1996 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-8622890